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Abstract Pseudo contact shifts (PCSs) induced by para-
magnetic lanthanide ions ﬁxed in a protein frame provide
long-range distance and angular information, and are
valuable for the structure determination of protein–protein
and protein–ligand complexes. We have been developing a
lanthanide-binding peptide tag (hereafter LBT) anchored at
two points via a peptide bond and a disulﬁde bond to the
target proteins. However, the magnetic susceptibility tensor
displays symmetry, which can cause multiple degenerated
solutions in a structure calculation based solely on PCSs.
Here we show a convenient method for resolving this
degeneracy by changing the spacer length between the
LBT and target protein. We applied this approach to PCS-
based rigid body docking between the FKBP12-rapamycin
complex and the mTOR FRB domain, and demonstrated
that degeneracy could be resolved using the PCS restraints
obtained from two-point anchored LBT with two different
spacer lengths. The present strategy will markedly increase
the usefulness of two-point anchored LBT for protein
complex structure determination.
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Abbreviations
NMR Nuclear Magnetic Resonance
PCS Pseudo contact shift
RDC Residual dipolar coupling
FKBP12 FK-506 binding protein 12
FRB FKBP12 rapamycin binding
DSF Differential scanning ﬂuorometry
LBT Lanthanide-binding peptide tag
Introduction
Long-range distance and angular information is useful for
the structural analysis of large proteins, multidomain pro-
teins and protein complexes (Gaponenko et al. 2002, 2004;
Battiste and Wagner 2000; Vlasie et al. 2007; Tang and
Clore 2006; Rumpel et al. 2007; Bertini et al. 2009).
Paramagnetic lanthanide ions induce several NMR effects
on observed nuclei, including pseudo-contact shifts (PCSs)
and residual dipolar couplings (RDCs) due to anisotropy of
the magnetic susceptibility tensor (Dv-tensor; Bertini et al.
2005, 2008; Otting 2008). PCSs provide distance and
angular information between the lanthanide ion and the
observed nuclei situated up to approximately 40 A ˚ from
the lanthanide ion (Allegrozzi et al. 2000), whereas RDCs
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distance (Bertini et al. 2001; Barbieri et al. 2002). There-
fore, paramagnetic lanthanide ions are useful probes for
solution structure determination by NMR and have been
applied successfully to metalloproteins (Bertini et al. 2001,
2004, 2007; Barbieri et al. 2002; Pintacuda et al. 2006,
2007; Allegrozzi et al. 2000). Metal ions such as Ca
2? and
Mg
2? ions can be replaced by lanthanide ions as they share
similar chemical properties. However, these approaches are
limited, in principle, to metalloproteins.
For the application of paramagnetic lanthanide probes to
non-metalloproteins, a wide variety of lanthanide-anchor-
ing tags has been developed, including lanthanide binding
peptide tags (Su et al. 2006, 2008a; Gaponenko et al. 2000;
Wohnert et al. 2003; Martin et al. 2007; Ma and Opella
2000; Zhuang et al. 2008) and synthetic lanthanide che-
lating reagents (Dvoretsky et al. 2002; Haberz et al. 2006;
Pintacuda et al. 2004; Prudencio et al. 2004; Rodriguez-
Castaneda et al. 2006; Ikegami et al. 2004; Leonov et al.
2005; Gaponenko et al. 2002, 2004; Vlasie et al. 2007;
Keizers et al. 2007, 2008; Su et al. 2008b; Swarbrick et al.
2011a, b; Graham et al. 2011). These tags are attached to
the target proteins through N- or C-terminal fusion
(Gaponenko et al. 2000; Wohnert et al. 2003; Martin et al.
2007; Ma and Opella 2000; Zhuang et al. 2008), insertion
into the loop region (Barthelmes et al. 2011) or the for-
mation of a disulﬁde bond with cysteine residues (Su et al.
2006, 2008a, b; Dvoretsky et al. 2002; Haberz et al. 2006;
Pintacuda et al. 2004; Prudencio et al. 2004; Ikegami et al.
2004; Leonov et al. 2005; Gaponenko et al. 2002, 2004;
Vlasie et al. 2007; Keizers et al. 2007, 2008; Swarbrick
et al. 2011a, b; Graham et al. 2011). However, the mobility
of the tag relative to the target protein reduces the aniso-
tropic paramagnetic effect (Bertini et al. 2004, 2007;S u
et al. 2008a). Hence, rigidity of the tag relative to the target
protein is necessary for obtaining quantitative structural
information using paramagnetic lanthanide probes.
The two-point anchoring method affords a promising
approach to the rigid ﬁxation of the lanthanide binding tag
to the target protein. The symmetrically designed synthetic
chelators can be anchored to the protein via two disulﬁde
bonds (Keizers et al. 2007, 2008). Most of these tags,
however, are not commercially available at present.
Recently, we reported a method that utilizes a lanthanide-
binding peptide tag, CYVDTNNDGAYEGDEL (LBT;
Nitz et al. 2003, 2004; Su et al. 2006, 2008a), linked to the
target protein via two anchoring points, a disulﬁde bridge
and an N-terminal fusion (Saio et al. 2009). This two-point
anchored LBT has one advantage for protein NMR
research in that it can be expressed as a fusion protein with
the target protein using E. coli. This method was ﬁrst
applied to the B1 immunoglobulin binding domain of
protein G (GB1) as a model protein to evaluate the
Dv-tensor of the paramagnetic lanthanide ion (Saio et al.
2009). We then applied two-point anchored LBT to the
PCS-based structure determination of protein–protein
complexes (Saio et al. 2010), drug screening, and structure
determination of drug–protein complexes (Saio et al.
2011). However, the magnetic susceptibility tensor has
symmetry, and thus gives eight degenerate solutions in a
structure determination based solely on PCS restraints
(Saio et al. 2010). This degeneracy cannot be fully resolved
by the combined use of multiple PCS data sets derived
from several lanthanide ions. In order to overcome this
degeneracy, it is crucial to obtain another PCS data set that
possesses a different orientation of the principal axes and a
different position of the paramagnetic center relative to the
target protein. Several sets of the data are available by
introducing the tag into different positions on the target
protein. In many cases, however, the identiﬁcation of
additional ﬁxation points for tagging is not straightforward.
Here we show that the direction of the principal axes of
the Dv-tensor and the metal position relative to the target
protein can be conveniently modulated by modifying the
spacer length between LBT and the target protein. This was
conﬁrmed for three proteins, the GB1, FKBP12 and Grb2
SH2 domains. Moreover, we applied this approach to the
PCS-based rigid body docking between the FKBP12-rap-
amycin complex and the mTOR FRB domain, and dem-
onstrated that the degeneracy could be resolved by using
PCS restraints obtained from two LBT-attached constructs
of different spacer lengths with three and four amino acid
residues. The present study will markedly increase the
usefulness of the two-point anchored LBT for protein
complex structure determination.
Materials and methods
Construction of the expression plasmid
The fragment encoding the FRB domain (2015–2114) of
human mTOR (GenBank ID of AAA58486) and the frag-
ment encoding full-length human FKBP12 (GenBank ID of
AAA35844) were cloned into pGBHPS (Kobashigawa
et al. 2009). For construction of the expression vector of
LBT-attached FKBP12, the fragment encoding FKBP12
(2–107) was cloned into pGTL (Saio et al. 2010; Supple-
mentary Fig. 1). The expression vectors for LBT-attached
GB1 and Grb2 SH2 were constructed as described previ-
ously (Saio et al. 2009, 2011).
Protein expression and puriﬁcation
Two-point anchored LBT-attached Grb2 SH2 and GB1
were prepared as described previously (Saio et al. 2009,
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1232011). FKBP12, two-point anchored LBT-attached
FKBP12, and the FRB domain of mTOR were prepared as
follows. Proteins were expressed at 25 Ci nE. coli strain
Rossetta2 (DE3). For the unlabeled samples, cells were
grown in Luria–Bertani media. For the uniformly
15N- or
13C/
15N-labeled samples, cells were grown in M9 media
containing
15NH4Cl (2 g/L), Celtone-N powder (0.2 g/L)
(Cambridge Isotope Laboratories, USA) and unlabeled
glucose (10 g/L), or
15NH4Cl (2 g/L), Celtone-CN powder
(0.2 g/L) (Cambridge Isotope Laboratories, USA) and
[U–
13C] glucose (4 g/L), respectively. We also prepared an
inversely labeled sample under a
15N background. For
preparation of the inversely labeled sample, 1 g/L of non-
labeled amino acid (A, H, K, M, R or W) or a combination
of non-labeled amino acids (F/Y, L/V or A/F/H/I/K/L/M/R/
V/W/Y) was added. Considering both the previous results
of inversely amino acid selective-labeling (Krishnarjuna
et al. 2010) and amino acid biosynthesis pathway of E. coli
(Waugh 1996), we selected single or combination of amino
acids each of which was assumed to exhibit low isotope
scrambling. Consistent with the previous results (Krish-
narjuna et al. 2010), signal intensity of Ile was reduced by
isotope scrambling in L/V inversely amino acid selective-
labeled sample. FKBP12 without two-point anchored LBT
was puriﬁed using Ni–NTA resin (Qiagen) afﬁnity chro-
matography, followed by tag removal by HRV3C protease
and gel ﬁltration using Superdex75 (GE Healthcare). LBT-
attached FKBP12 was puriﬁed by afﬁnity chromatography
using glutathione Sepharose 4B (GE Healthcare), followed
by gel-ﬁltration using Superdex75 (GE Healthcare). After
gel-ﬁltration, LBT-attached FKBP12 was incubated with
1m M5 ,5 0-ditiobis(2-nitrobenzoic acid) (DTNB) for 2 h at
4 C to link the N-terminal Cys of LBT and the Cys on the
target proteins via an intramolecular disulﬁde bond (Saio
et al. 2009). The reaction was performed under low
FKBP12 concentration ranging from 10 to 20 lM. Rapa-
mycin was added to the FKBP12 sample before starting the
oxidization reaction. The oxidized two-point anchored
LBT-attached proteins were further puriﬁed by gel-ﬁltra-
tion chromatography on a Superdex 75 (GE Healthcare).
The FRB domain of mTOR was expressed in the inclusion
body, and retrieved by high-pressure refolding (Schoner
et al. 2005; Qoronﬂeh et al. 2007; Saio et al. 2010). Details
of the refolding process will be published elsewhere.
Differential scanning ﬂuorometry
A real-time PCR device (Mx3005p, Stratagene) was used
to monitor protein unfolding by tracking increase in the
ﬂuorescence intensity of the ﬂuorophore SYPRO Orange
(Sigma). SYPRO Orange was diluted to 1:60 with 20 mM
MES buffer (pH 7.0) containing 150 mM NaCl, and used
as stock solution for DSF measurement. SYPRO Orange
stock solution (2.5 lL) was mixed with 22.5 lL of the L1-
to L5-FKBP12-rapamycin complex (10 lM) containing
one equivalent molar of LuCl3 in 20 mM MES and
150 mM NaCl (pH 7.0). They were incubated in optical
cap sample tubes (strips of 8; Agilent Technologies) in the
RT-PCR device. The samples were heated at 1 C per min,
from 35 to 95 C. After base-line correction, the unfolding
fractions were estimated and plotted against temperature.
NMR spectroscopy
Samples were prepared in 20 mM MES buffer (pH 7.0) with
150 mM NaCl for FKBP12-rapamycin, FRB-rapamycin and
FKBP12-rapamycin-FRB, in 20 mM MES buffer (pH 6.5)
with 50 mM NaCl for the GB1, and in 20 mM Tris buffer (pH
7.2) with 100 mM NaCl for the Grb2 SH2 domain. For the
assignment of the
1H,
15Na n d
13C resonances of FKBP12-
rapamycin, FRB-rapamycin and FKBP12-rapamycin-FRB, a
standardsetofheteronuclearNMRspectrawererecordedusing
Protein Pack pulse sequences (Varian, Inc., Palo Alto, CA,
USA). For the assignment of FRB in the FKBP12-rapamycin-
FRB ternary complex,
1H–
15N HSQC spectra of seven inver-
sely amino acid selective-labeled samples (A, H, K, M, R, W,
F/Y or L/V) were used for amino acid type determination and
conﬁrmation of the assignment. For assignment of the PCS
peaks of FKBP12-rapamycin, the
1H–
15NH S Q Cs p e c t r u mo f
an eleven amino acid (A/F/H/I/K/L/M/R/V/W/Y) inversely
labeled sample was also used to reduce spectral overlap. The
signal assignments and PCS assignments for GB1 and Grb2
SH2 were conducted as described previously (Saio et al. 2009,
2011). All NMR experiments were performed on Inova 800,
600 or 500 MHz NMR spectrometers (Varian, USA) at 25 C.
SpectrawereprocessedusingtheNMRPipeprogram(Delaglio
etal.1995)anddataanalysiswasperformedwiththehelpofthe
Olivia program developed in our laboratory (Yokochi et al.
http://fermi.pharm.hokudai.ac.jp/olivia/).
Tensor calculation
The Dv-tensors for the FKBP12-rapamycin complex, GB1
and Grb2 SH2 domains were calculated from the PCS
values and the structure of the FKBP12-rapamycin com-
plex (Van Duyne et al. 1991, 1fkb.pdb), and the GB1 (Saio
et al. 2009, 2rpv.pdb) and Grb2 SH2 domains (Ogura et al.
2008, 1x0n.pdb) based on Eq. (1) using the Numbat pro-
gram (Schmitz et al. 2008),
Dd
pcs ¼
1
12pr3 Dvax 3cos2 h   1

þ
3
2
Dvrh sin2 hcos2/

ð1Þ
where Dd
PCS is the pseudo contact shift, r, h and / are the
polar coordinates of the nucleus with respect to the
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123principal axis of the magnetic susceptibility tensor, and
Dvax and Dvrh are the axial and rhombic components of the
magnetic susceptibility tensor.
Docking
PCS-based rigid body docking was carried out using the
Xplor-NIH program (Schwieters et al. 2003, 2006),
equipped with PARA restraints for Xplor-NIH (Banci et al.
2004). At the start of the docking calculation, the relative
orientation and position of the FRB domain were ran-
domized to generate 100 starting structures that were
located within 100 A ˚ from the FKBP12. The coordinates of
the metal were ﬁxed at the positions which were deter-
mined by Dv-tensor-ﬁts from the PCSs observed for the
L3-FKBP12-rapamycin and L4-FKBP12-rapamycin com-
plexes. The FRB domain moiety from the FKBP12-rapa-
mycin-FRB ternary complex (Liang et al. 1999, 1fap.pdb)
was used for docking studies. We used the coordinates of
the FKBP12 moiety in this complex for rigid body docking
studies, since we determined the Dv-tensor values for
FKBP12 using FKBP12-rapamycin binary complex (Van
Duyne et al. 1991, 1fkb.pdb). As the structures of the
rapamycin moieties in the binary and ternary complexes
differ from each other in the FRB binding region, which
could cause a steric crash with the FRB domain in the
rigid-body docking calculation, therefore we omitted
the rapamycin moiety during the docking calculation. The
rigid body docking calculation was performed based on the
PCS restraints. During the calculation, the coordinates of
FKBP12 and the metal were ﬁxed, whereas those of FRB
were freely rotated and translated. For the PCS restraints,
pseudo atoms representing the Dv-tensor axes were intro-
duced. The atom representing the origin of the axis was
restrained within 0.02 A ˚ of the metal, while the coordinates
of the Dv-tensor were freely rotated around the origin. The
target function was calculated based on two terms: the least
square energy penalty for PCS restraints (EPCS; Banci et al.
2004), and a quartic van der Waals repulsion term (Erepel).
O ¨ radius scale factor was decreased from 1.0 to 0.78. The
Xplor-NIH script for the docking calculation is provided as
Supporting Information.
Results
Design and differential scanning ﬂuorometry analysis
of two-point anchored LBT-attached FKBP12
In the crystal structure of FKBP12 (Van Duyne et al.
1991), the well-deﬁned secondary structure starts from V2.
We, therefore, omitted G1 and deﬁned the structured
region of FKBP12 in all the two-point anchored LBT-
attached FKBP12 constructs in this study. The distance
between the Ca atoms of the N- and C-terminal residues is
around 7 A ˚ in the crystal structure of LBT (Nitz et al.
2004). We searched for a residue about 7 A ˚ in distance
from V2 of FKBP12, and found T75. The Ca distance
between V2 and T75 was 5.6 A ˚. Thus we introduced the
T75C mutation to FKBP12, and LBT was fused to the
N-terminus of the FKBP12 (T75C). A spacer was intro-
duced between the LBT and V2 of FKBP12 to avoid
structural distortion and steric hindrance. We prepared
constructs containing one- (H-), two- (H-M), three- (H-M-
G), four- (H-M-S-G) and ﬁve-residue (H-M-G-S-G) link-
ers, named L1-, L2-, L3-, L4- and L5-FKBP12, respec-
tively (Fig. 1a). These constructs were ﬁrst screened for
their suitability for NMR experiments, based on melting
temperature (Tm) measured using differential scanning
ﬂuorometry (DSF; Niesen et al. 2007) in the presence of
Lu
3?, since we assumed that Tm was sensitive to the
structural distortion and/or hindrance. Figure 1b shows the
unfolding curves, and Table 1 lists the Tm values of Lu
3?-
bound L1- to L5-FKBP12-rapamycin. The unfolding
curves of L3- to L5-FKBP12-rapamycin were almost
identical, while those of L1- and L2-FKBP12-rapamycin
were shifted to a lower temperature. The melting temper-
atures of L3- to L5-FKBP12-rapamycin were estimated to
be around 72 C, while those of L1- and L2-FKBP12-
rapamycin were lower by 4 and 3.5 C, respectively. From
this observation, L1- and L2-FKBP12-rapamycin were
assumed to exhibit structural distortion and/or hindrance.
This was also conﬁrmed by the comparison of the
1H–
15N
HSQC spectra of these constructs complexed with Lu
3?
(Fig. 1c). The residues indicating spectral shifts on the
attachment of the two-point anchored LBT were located
very close to the anchoring points in the case of L3- to L5-
FKBP12-rapamycin, while a large shift was observed for
G62 (highlighted in Fig. 1d) on the a-helix region close to
the N-terminal anchoring point in the case of L1- and L2-
FKBP12-rapamycin. From NMR and DSF analyses, a lin-
ker with more than three amino acid residues was required
for FKBP12 to avoid structural distortion and/or hindrance
on the attachment of two-point anchored LBT.
NMR analysis and tensor calculation of L3-and
L4-FKBP12-rapamycin
Considering the results of DSF and NMR analyses, we
prepared three two-point anchored LBT-attached con-
structs, L3- to L5-FKBP12. Using these constructs, we
examined the effect of spacer length on the principal axis
of the Dv-tensor and the metal position relative to the target
protein. Figure 2a and b show the overlay spectra of Dy
3?,
Lu
3? and Tb
3?-bound L3- (Fig. 2a) and L4-FKBP12-rap-
amycin (Fig. 2b), respectively. The peak shift pattern of
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123L3-FKBP12-rapamycin was different from that of L4-
FKBP12-rapamycin, showing differences in the Dv-tensor.
On the other hand, L4- and L5-FKBP12-rapamycin
exhibited similar PCS values (Supplementary Fig. 2), and
were assumed to exhibit similar Dv-tensors and metal
positions relative to the target protein. Hence, we estimated
the Dv-tensors for only L3- and L4-FKBP12-rapamycin
from the PCS values using the Numbat program (Schmitz
et al. 2008). For assignment of the PCS peaks, the
1H–
15N
HSQC spectrum of an eleven amino acid (A/F/H/I/K/L/M/
R/V/W/Y) inversely labeled sample was also used to
reduce spectral complexity (Supplementary Fig. 3). Based
on the PCS values from the two lanthanide ions, Tb
3? and
Dy
3?, Dv-tensors for each lanthanide were simultaneously
ﬁtted with the common metal position, due to their iso-
morphous nature, for L3- and L4-FKBP12-rapamycin,
respectively (Table 2). The Dv-tensors were well deﬁned
and the correlations between the experimental and back-
calculated PCS values were good (Supplemental Fig. 4).
This was also supported by the result of Monte-Carlo
analysis using the 100 partial PCS data sets in which 30 %
of the input data were randomly deleted (Supplemental
Fig. 4). Moreover, the magnitudes of the tensors were
comparable between L3- and L4-FKBP12-rapamycin as
well as to those reported previously (for two-point
anchored LBT-attached GB1; Saio et al. 2009, for the p62
PB1 domain; Saio et al. 2010 and for the Grb2 SH2
Fig. 1 a Schematic
representation of the two-point
anchored LBT-attached
FKBP12 construct. The spacer
sequence is enclosed in the box.
b The thermal unfolding curve
of two-point anchored LBT-
attached FKBP12 in the
presence of one equivalent
molar Lu
3?. c Overlay of the
1H–
15N HSQC spectra of
FKBP12 (T75C) without the
two-point anchored LBT (blue),
and L1- (green), L2- (black),
L3- (red), L4- (dark yellow) and
L5-FKBP12 (gray) in the
presence of 1 equivalent molar
Lu
3?. Inset shows peaks arising
from G62. d Anchoring point,
V2 and T75C (colored blue),
and G62 (colored red) were
mapped on the structure of
FKBP12
Table 1 Melting temperature of L1-, L2-, L3-, L4- and L5-FKBP12
in the presence of Lu
3? estimated using DSF
Tm (C) DTm (C)
a
L1-FKBP12 67.4 (±0.05) 0
L2-FKBP12 68.0 (±0.04) 0.6
L3-FKBP12 71.2 (±0.11) 3.8
L4-FKBP12 71.0 (±0.26) 3.6
L5-FKBP12 70.8 (±0.10) 3.4
a DTm: Difference of the Tm with L1-FKBP12
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123domain; Saio et al. 2011). Thus, we concluded that the
positions of the lanthanide ions as well as the Dv-tensor
parameters for L3- and L4-FKBP12-rapamycin were
accurately determined. In contrast to the similarity in
magnitude of the Dv-tensors between L3- and L4-FKBP12-
rapamycin, the direction of the principal axes of the
Dv-tensors relative to the attached protein differed by about
30–40 when compared with the same metal ion (Table 2;
Fig. 2c, d). Moreover, the metal positions of these two
constructs differed by about 5.2 A ˚ (Fig. 2e). These obser-
vations suggest that the PCSs obtained from the two-point
anchored LBT-attached proteins with different spacer
lengths could be used as independent restraints for struc-
tural calculation.
Design, NMR analysis and tensor calculation
of L3- and L4-GB1 and L4- and L5-Grb2
To conﬁrm whether the metal position and the principal
axes of the Dv tensor relative to the attached protein could
be generally modulated by changing the spacer length
between two-point anchored LBT and the attached protein
in general, we studied two-point anchored LBT-attached
GB1 and Grb2 SH2. In our previous paper, L1-, L2 and L3-
GB1 was prepared and the
1H–
15N HSQC spectra were
measured in the presence of Tm
3?, and revealed that L1-
and L2-GB1 exhibited double peaks, while single in L3-
GB1 (Saio et al. 2009). Hence we assumed that architecture
of LBT was disturbed by the steric hindrance due to
Fig. 2 Overlay of the
1H–
15N
HSQC spectra of L3-FKBP12
(a) and L4-FKBP12 (b) in the
presence of one equivalent
molar Lu
3? (blue), Dy
3?
(green) and Tb
3? (black).
Graphical views of the PCS
isosurface of Dy
3? for L3-
FKBP12 (c) and L4-FKBP12
(d). Positive and negative PCS
values are indicated by blue and
red, respectively. e Metal
positions of L3- and L4-
FKBP12. Metal positions are
shown in ball (red for L3 and
blue for L4)
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123inappropriate linker length, and we concluded that three
residue linker was the minimum spacer length. Moreover,
we prepared L3-, L4 and L5-Grb2 SH2 in the previous
study (Saio et al. 2011), and showed that L3-Grb2 SH2
exhibited broad NMR signals, while sharp signals in L4-
and L5-Grb2 SH2 domain. From these observations, we
assumed that the minimum spacer length of Grb2 SH2 was
four residues. Based both on the previous result for GB1
and Grb2 SH2, and the present result of FKBP12, we
prepared L5-Grb2 SH2 and L4-GB1 constructs for the
Dv-tensor analysis. The principal axes of the Dv-tensors
and the metal positions for L3- and L4-GB1, and L4- and
L5-Grb2 SH2 were evaluated in a manner similar to that
for FKBP12-rapamycin. The magnitudes of the Dv-tensors
were comparable among the L3- and L4-GB1, L4- and L5-
Grb2 SH2, and FKBP12-rapamycin as well as to those
reported previously (for two-point anchored LBT-attached
GB1; Saio et al. 2009, for the p62 PB1 domain; Saio et al.
2010 and for the Grb2 SH2 domain; Saio et al. 2011). It
could be concluded that the position of the lanthanide ion
as well as the Dv-tensor parameters for L3- and L4-GB1,
and L4- and L5-Grb2 SH2 were accurately determined,
since the Dv-tensor parameters were well deﬁned and the
correlations between the experimental and back-calculated
PCS values were good (Supplemental Fig. 5 and Supple-
mental Fig. 6). This was also supported by the result of
Monte-Carlo analysis using the 100 partial PCS data sets in
which 30 % of the input data were randomly deleted
(Supplemental Fig. 5 and Supplemental Fig. 6). The prin-
cipal axes of the Dv-tensors differed by about 20–30
between L3- and L4-GB1, and by about 10–20 between
L4- and L5-Grb2 SH2 for the same metal ions (Table 2).
Moreover, the metal positions in L3- and L4-GB1 differed
by about 4.3 A ˚ (Supplemental Fig. 6), while those in the
L4- and L5-Grb2 SH2 domains differed by about 0.7 A ˚
(Supplemental Fig. 5). Thus, both the principal axes of the
Dv-tensor and the metal positions relative to the attached
protein can be modulated by changing the spacer length
between the two-point anchored LBT and the attached
protein.
Table 2 Dv-tensor parameters for lanthanide ions in complex with
L3-FKBP12-rapamycin, L4-FKBP12-rapamycin, L3-GB1, L4-GB1,
L4-Grb2 SH2 and L5-Grb2 SH2 determined on the basis of the crystal
structure of the FKBP12-rapamycin complex (PDBID: 1fkb), GB1
(PDBID: 2rpv), Grb2 SH2 domains (PDBID: 1x0n) and the PCS
values obtained from L3-FKBP12, L4-FKBP12, L3-GB1, L4-GB1,
L4-Grb2 SH2 and L5-Grb2 SH2 signals
Dvax
a Dvrh
a a
b b
b c
b
L3-FKBP12 (Dy
3?) 23.1 (±1.8) 20.2 (±1.2) 49 106 31
L3-FKBP12 (Tb
3?) 34.0 (±2.5) 13.4 (±2.1) 53 106 17
L4-FKBP12 (Dy
3?) 23.1 (±1.6) 19.0 (±0.7) 33 77 38
L4-FKBP12 (Tb
3?) 29.2 (±1.2) 17.9 (±0.5) 35 69 9
L3-GB1 (Tm
3?) -18.5 (±0.9) -18.0 (±0.4) 66 148 149
L3-GB1 (Tb
3?) 39.2 (±1.0) 15.9 (±2.1) 97 145 158
L3-GB1 (Er
3?) -9.4 (±0.7) -7.0 (±0.2) 71 138 136
L4-GB1 (Tm
3?) -23.6 (±1.2) -20.0 (±0.7) 85 127 160
L4-GB1 (Tb
3?) 41.8 (±2.3) 20.4 (±0.6) 94 125 153
L4-GB1 (Er
3?) -9.3 (±0.8) -8.4 (±0.4) 74 115 145
L4-Grb2 SH2 (Dy
3?)
c 22.7 (±1.3) 17.6 (±0.7) 106 57 53
L4-Grb2 SH2 (Tb
3?)
c 29.2 (±1.7) 16.9 (±0.5) 97 52 34
L4-Grb2 SH2 (Tm
3?)
c -17.5 (±1.6) -17.1 (±0.5) 99 65 27
L5-Grb2 SH2 (Dy
3?) 25.1 (±2.2) 21.0 (±1.2) 113 41 51
L5-Grb2 SH2 (Tb
3?) 30.2 (±2.6) 21.1 (±1.0) 100 42 37
L5-Grb2 SH2 (Tm
3?) -19.0 (±1.7) -19.1 (±1.0) 97 45 34
Dv-tensor parameters were determined relative to the conformer 1 of the family of NMR structures of FKBP12-rapamycin complex (1fkb.pdb),
GB1 (2rpv.pdb) and Grb2 SH2 (1x0n.pdb). Metal ion coordinates were x = 19.155 (±0.340), y =- 17.082 (±0.199), z = 13.38 (±0.314) for
L3-FKBP12, x = 15.782 (±0.258), y =- 19.799 (±0.108), z = 10.386 (±0.263) for L4-FKBP12, x =- 3.78 (±0.413), y =- 2.12 (±0.548),
z =- 10.078 (±0.396) for L3-GB1, x =- 1.036 (±0.224), y =- 3.8 (±0.323), z =- 12.954 (±0.219) for L4-GB1, x =- 13.093 (±0.186),
y =- 5.491 (±0.404), z =- 5.046 (±0.325) for L4-Grb2 SH2 and x =- 13.270 (±0.304), y =- 6.009 (±0.409), z =- 5.562 (±0.515) for
L5-Grb2 SH2. Deviation of the metal position was obtained by the Monte-Carlo protocol using 100 partial PCS data sets in which 30 % of the
input data were randomly deleted
a Dvax and Dvrh values are in 10
-32 [m
3] and error estimates were obtained by the Monte-Carlo protocol using 100 partial PCS data sets in which
30 % of the input data were randomly deleted
b Euler angle rotations in ZYZ convention (degrees)
c Saio et al. (2011)
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123PCS-restraint based rigid body docking
of the FKBP12-rapamycin-FRB complex
We next studied whether the present approach could be
used for resolving the degeneracy problem in PCS-based
structure calculation. We initially conﬁrmed that FRB
moiety of FRB/rapamycin/L3-FKBP12 ternary complex
exhibited different PCS pattern as compared to the FRB/
rapamycin/L4-FKBP12 (Supplementary Fig. 7). Next, the
structure of the FKBP12-FRB complex was calculated
based solely on PCS restraints, and compared with the
crystal structure (Liang et al. 1999). First, rigid body
docking calculations were performed for L3- and L4-
FKBP12 separately, using two PCS data sets derived from
Dy
3? and Tb
3?. The docking structure determined using
PCS data sets derived from two lanthanide ions still affords
four degenerate solutions (Fig. 3a, b). This is consistent
with our previous result (Saio et al. 2010).
PCSs can also be expressed by Eq. (2) (Bertini et al.
2002):
Dd
pcs ¼
1
12pr3 Dvax
2z2   x2   y2
r2 þ
3
2
Dvrh
x2   y2
r2

ð2Þ
where x, y and z are the Cartesian coordinates of the
nuclear spin in the Dv-tensor frame, r is the distance
between the nuclear spin and the paramagnetic centre, and
Dvax and Dvrh are the axial and rhombic components of the
Dv-tensor. From Eq. (2), PCSs from a single metal exhibit
eight degenerated solutions, in principle, since PCS values
do not depend on the sign of the x, y, and z axes. The
degenerate solutions can be eliminated in case of calcula-
tions based on PCS data sets from multiple lanthanide ions,
since the x, y and z directions of the principal axes of the
Dv-tensor vary among the lanthanide ions ﬁxed in the same
position (Saio et al. 2009, 2010, 2011). In this study, the
directions of the x and y axes mainly differed by 20–30
between Tb
3? and Dy
3?, which was represented as the
difference in the c term of the Euler angles (Table 2), thus
restricting four solutions (Fig. 3a, b).
We next combined the PCS restraints derived from the
L3- and L4-FKBP systems, and performed a rigid body
docking calculation based on four PCS data sets: the PCSs
of Dy
3? and Tb
3? observed for both the L3- and L4-
FKBP12 system. The Dv-tensor parameters were well
deﬁned and the correlations between the experimental and
back-calculated PCS values were good (Supplemental
Fig. 8). Figure 3c shows an overlay of the 20 lowest energy
structures of the FKBP12-rapamycin-FRB complex
superimposed on FKBP12 region. FRB regions were con-
verged with the main chain atom RMSD of 0.69 A ˚
(±0.58 A ˚), and position of the FRB relative to FKBP12
were well deﬁned. Moreover, combined use of the PCS
data sets with different lanthanide ion positions as well as
the different directions of the tensor axes successfully
resolved the degeneracy, thus structural determination of
the FKBP12-FRB complex can be achieved. We also show
an overlay of the lowest energy structure of the PCS-based
Fig. 3 The PCS-based docking structure between the FKBP12-rapa-
mycin and FRB domains. Since PCS data were not obtained for
rapamycin, rapamycin was omitted during the structure calculation.
a Calculated FKBP12-FRB complex structure based on PCS data from
L3-FKBP12 using two metals, both Dy
3? and Tb
3?. b Calculated
FKBP12-FRB complex structure based on PCS data from L4-FKBP12
using two metals, both Dy
3? and Tb
3?. c Calculated FKBP12-FRB
complex structure based on PCS data from both L3- and L4-FKBP12
using two metals, both Dy
3? and Tb
3?.T h r o u g h( a)t o( c), obtained
structures were superimposed on FKBP12 moiety. In (a), (b)a n d( c),
metalpositionsareshowninball(redforL3andblueforL4),FKBP12in
green ribbon and FRB in magenta stick. d Ribbon representation of the
PCS-based structure (green for FKBP12 and magenta for FRB) and the
crystal structure of FKBP12/rapamycin/FRB ternary complex (Liang
et al. 1999, 1fap.pdb; cyan ribbon for FKBP12, orange stick for
rapamycin and blue ribbon for FRB). The lowest energy structure of the
PCS-basedstructureoftheFKBP12-FRBcomplexwassuperimposedon
FKBP12 moiety of the crystal structure of the ternary complex (Liang
et al. 1999, 1fap.pdb). The main chain atom RMSD of the FKBP12
moietyinthebinaryandtheternarycomplexeswasestimatedtobe0.5A ˚.
ThemainchainatomRMSDoftheFRBmoietyintheternarycomplexof
the crystal structure and the PCS-based NMR structure was estimated to
be 2.9 A ˚
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123FKBP12-FRB complex superimposed on FKBP12 region
of the ternary complex determined by X-ray crystallogra-
phy (Liang et al. 1999, 1fap.pdb) in Fig. 3d. The position
and orientation of FRB domain relative to FKBP12 cor-
respond well to those of the structure determined by X-ray
crystallography (Liang et al. 1999, 1fap.pdb). Since we
omitted the rapamycin during the docking calculation,
relative orientation between FKBP12 and FRB could be
determined solely by PCS-restraints not by complementary
of the surface shape. FRB region of PCS-based structures
were converged with the main chain atom RMSD of 2.9 A ˚,
which validates the PCS-based structure obtained using the
present method. Slight difference between the complex
structures obtained by PCS and crystal might be caused by
the limitation of the PCS-based docking, presumably
structural change of FKBP12 according to association with
FRB (the main chain atom RMSD of the FKBP12 moiety
in the binary and the ternary complexes was estimated to be
0.5 A ˚) and/or the experimental error of the PCS values etc.
It should be also noted that the correlations between the
experimental and back-calculated PCS values were good
(Supplemental Fig. 8), which supports the compatibility of
the docking structure.
Discussion
In the present study, we demonstrated that two-point
anchored LBT accommodates at least two sets of different
spacer lengths, which change the orientation of the LBT,
thus changing the direction of the principal axis of the Dv-
tensor and the metal position relative to the attached pro-
tein. We applied this method to three proteins, FKBP12,
GB1 and Grb2 SH2, and showed that the two-point
anchored LBT-attached target proteins with different
spacer length with minimum and ‘minimum plus one’
spacer length could change the orientation of the principal
axes of the Dv-tensor and the metal position, relative to the
attached proteins. Moreover, we demonstrated that the
degeneracy problem could be overcome by the use of the
PCS data sets derived from the constructs with different
spacer lengths.
In our previous study, we reported a vector to construct
an expression plasmid for a two-point anchored LBT-
attached protein. The vector codes the N-terminus GST for
afﬁnity puriﬁcation, the TEV protease cleavage site for
GST-tag removal, the LBT and multiple cloning sites for
the introduction of the cDNA fragment of the target protein
(Saio et al. 2010 and Supplementary Fig. 1). By changing
the primer used for ampliﬁcation of the cDNA fragment,
the spacer length between the two-point anchored LBT and
the target protein can be easily changed. However, it is to
be noted that a longer spacer would result in increased
mobility of the lanthanide ion relative to the protein
framework and reduction of the anisotropic paramagnetic
effect. From the present results for FKBP12 and GB1, the
appreciable changes in the direction of the principal axis of
the Dv-tensor and the metal position were produced
between the three (minimum) and four (minimum plus one)
amino acid residue linkers. In case of FKBP12, both con-
structs with the four (minimum plus one) and ﬁve (mini-
mum plus two) residue linker exhibited almost identical
PCS values and are assumed to possess the almost identical
principal axis of the Dv-tensor and the metal position.
Therefore, a minimum spacer length should be deter-
mined. Table 3 lists Ca atom distances between the
N-terminus residue of the target and the anchoring point
disulﬁde bond, and the minimum spacer length between the
target and two-point anchored LBT applied to date. It could
be empirically assumed that the minimal spacer length was
three residues if the Ca atom distance was around 6 A ˚. For
the longer Ca atom distances, a longer spacer would be
required. Further analysis is required to obtain information
about the correlation between the Ca atom distance and the
spacer length where the Ca atom distance is much longer
than 6 A ˚. At least, this empirical ‘6 A ˚-three residue linker’
rule for the two-point anchored LBT will be helpful for the
design of the anchoring point to be mutated to Cys. Once
this anchoring point is designed, the stability of the con-
structs with the minimum and the minimum plus one
spacer lengths can be determined by DSF and/or NMR.
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Table 3 Spacer length between the two-point anchored LBT and
target proteins, and the distance between the Ca atoms of N-terminus
residue of the target and the anchoring residue disulﬁde bond
Anchoring
point
Ca atom
distance (A ˚)
Minimal spacer
length
GB1 M1-E19C 6.1 3
a
p62 PB1 domain S3-C26 6.0 3
b
FKBP12 V2-T75C 5.6 3
c
Grb2 SH2 domain W60-M73C 9.9 4
d
a Saio et al. (2009)
b Saio et al. (2010)
c Present study
d Saio et al. (2011)
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